Cargando…
Efficacy and safety of add-on anti-CD20 monoclonal antibody to Bruton tyrosine kinase inhibitor treatment for chronic lymphocytic leukemia: a meta-analysis
The efficacy of Bruton tyrosine kinase inhibitors (BTKi) remains suboptimal in chronic lymphocytic leukemia (CLL) treatment. A systematic review and meta-analysis were conducted to compare the outcomes of combining anti-CD20 monoclonal antibodies (mAb) with BTKi therapy versus BTKi monotherapy for p...
Autores principales: | Nguyen, Thi Thuy, Nhu, Nguyen Thanh, Tran, Van Khoi, Viet-Nhi, Nguyen-Kieu, Ho, Xuan Dung, Jhan, Ming-Kai, Chen, Ya-Ping, Lin, Chiou-Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276018/ https://www.ncbi.nlm.nih.gov/pubmed/37328530 http://dx.doi.org/10.1038/s41598-023-36279-x |
Ejemplares similares
-
Efficacy and Safety of Bruton Tyrosine Kinase Inhibitor Monotherapy Compared with Combination Therapy for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: A Systematic Review and Meta-Analysis
por: Nguyen, Thi Thuy, et al.
Publicado: (2023) -
Toothpick—a rare cause of bowel perforation: case report and literature review
por: Vo, Nhu Quynh, et al.
Publicado: (2020) -
Microencapsulation of roselle (Hibiscus sabdariffa L.) anthocyanins: Effects of drying conditions on some physicochemical properties and antioxidant activities of spray‐dried powder
por: Nguyen, Quoc‐Duy, et al.
Publicado: (2021) -
The evolving role of Bruton’s tyrosine kinase inhibitors in chronic lymphocytic leukemia
por: Gordon, Max J., et al.
Publicado: (2021) -
Effectiveness and safety of CD22 and CD19 dual‐targeting chimeric antigen receptor T‐cell therapy in patients with relapsed or refractory B‐cell malignancies: A meta‐analysis
por: Nguyen, Thi Thuy, et al.
Publicado: (2023)